Trillionaire club throws an indulgent theme party
The author is a Reuters Breakingviews columnist. The opinions expressed are his own. Refiles to fix spacing in paragraph three.
By Robert Cyran
NEW YORK, June 20 (Reuters Breakingviews) -The trillionaire club is growing quickly. Six years ago, Apple AAPL.O became the charter member, not long before oil titan Saudi Aramco 2223.SE publicly debuted with a 13-digit market capitalization. Few would have predicted five more inductees so soon, and investors are nudging even more companies to join. Chipmaker Broadcom AVGO.O is riding an artificial intelligence wave just like Nvidia NVDA.O, Microsoft MSFT.O, Amazon.com AMZN.O, Alphabet GOOGL.O and Meta Platforms META.O. Eli Lilly LLY.N is on its way thanks to the anti-obesity craze. Hyped megatrends sparking giddy valuations, however, will inevitably lead to disappointment.
Broadcom, under boss Hock Tan, has been expanding by acquisition. It bought several rivals before paying almost $70 billion last year for cloud-computing software developer VMware. The deals have enabled it to slash costs and raise prices. The $839 billion company’s total return for shareholders, including reinvested dividends, has been an eye-popping 3,200% over the past decade. Its AI-linked chips also have started to draw comparisons to Nvidia, which just overtook Microsoft as the world’s most valuable company and whose $3.3 trillion market cap exceeds the entire Russell 2000 Index .RUT.
Lilly, at $847 billion, is cashing in on the surging desire for weight-loss medications. Its Zepbound molecule, also used to treat diabetes, generated $5.3 billion of revenue last year. The only limitation now is production, as the market it shares with Novo Nordisk NOVOb.CO rumbles toward $100 billion annually by 2030, according to Goldman Sachs analysts.
The doubling of Broadcom’s and Lilly’s market values in a year makes thematic investing seem easy and the somewhat arbitrary expectations fun. Even Warren Buffett’s Berkshire Hathaway BRKa.N conglomerate is on track to be part of the group, boosted by its large holding of Apple stock. It’s easy to forget that fiberoptics and Dow 10,000 hats were all the rage in 1999, and darkly ironic a decade later.
Both the chipmaker and the drugmaker also face valid questions about whether their valuations reflect overly excessive growth projections. Lilly trades at 18 times anticipated revenue for the next 12 months, or more than 3 times peer Merck’s MRK.N multiple, based on LSEG data. Its patent protection will eventually lapse, however, and rivals could roll out better therapies even sooner.
Broadcom’s stock trades at 32 times estimated earnings, or twice its 10-year average. Its most recent quarterly revenue increased just 12% from a year earlier after excluding VMware’s contributions; semiconductor sales grew 6%. Other companies built around buying and cutting, such as cheese-and-ketchup purveyor Kraft Heinz KHC.O, have struggled to sustain the business model. It all makes the four-comma theme party look indulgent.
Follow @rob_cyran on X
CONTEXT NEWS
As of June 14, Apple, Microsoft, Nvidia, Alphabet, Amazon.com and Meta Platforms all had market capitalizations of more than $1 trillion. Saudi Arabian oil producer Saudi Aramco’s valuation also exceeded the threshold.
Graphic: Lilly and Broadcom make outperformance look easy Lilly and Broadcom make outperformance look easy https://reut.rs/3VHtMN3
Editing by Jeffrey Goldfarb and Sharon Lam
Aloqador aktivlar
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
